Drug Patents owned by Belcher

1. Drug name - EPINEPHRINE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039728 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use Aug, 2034

(11 years from now)

US10004700 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use Aug, 2034

(11 years from now)

US9283197 BELCHER More potent and less toxic formulations of epinephrine and methods of medical use Aug, 2034

(11 years from now)

Drugs and Companies using EPINEPHRINE ingredient

Treatment: Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type 1), including anaphylaxis; a method of treating allergic reaction, anaphylaxis, anaphylactic shock, or combination thereof by an injection of at least one dosage of the injectable liquid pharmaceutical; Emergency treatment of allergic reactions (type i), including anaphylaxis; increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; induction and maintenance of mydriasis during intraocular surgery

Dosage: SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 1MG BASE/ML (EQ 1MG BASE/ML) SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.